Cargando…

STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population

Cancer stem cells (CSCs) are a small subpopulation of quiescent cells with the potential to differentiate into tumor cells. CSCs are involved in tumor initiation and progression and contribute to treatment failure through their intrinsic resistance to chemo- or radiotherapy, thus representing a subs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canesin, Giacomo, Maggio, Valentina, Palominos, Macarena, Stiehm, Anna, Contreras, Hector R., Castellón, Enrique A., Morote, Juan, Paciucci, Rosanna, Maitland, Norman J., Bjartell, Anders, Hellsten, Rebecka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434889/ https://www.ncbi.nlm.nih.gov/pubmed/32811873 http://dx.doi.org/10.1038/s41598-020-70948-5

Ejemplares similares

The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
por: Hellsten, Rebecka, et al.
Publicado: (2022)

The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
por: Hellsten, Rebecka, et al.
Publicado: (2019)

Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
por: Hellsten, Rebecka, et al.
Publicado: (2011)

Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
por: Canesin, Giacomo, et al.
Publicado: (2017)

Expression of tSTAT3, pSTAT3(727), and pSTAT3 (705) in the epithelial cells of hormone‐naïve prostate cancer
por: Krzyzanowska, Agnieszka, et al.
Publicado: (2019)

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
por: Witt, Kristina, et al.
Publicado: (2021)

Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
por: Thaper, Daksh, et al.
Publicado: (2018)

The role of prostate tumor overexpressed 1 in cancer progression
por: Cánovas, Verónica, et al.
Publicado: (2016)

Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer
por: Ko, Hyejin, et al.
Publicado: (2019)

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
por: Canesin, Giacomo, et al.
Publicado: (2020)

Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells
por: García, Víctor, et al.
Publicado: (2015)

Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice
por: Bollmann, Franziska, et al.
Publicado: (2015)

Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
por: Castellón, Enrique A., et al.
Publicado: (2022)

Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
por: Englund, Emelie, et al.
Publicado: (2017)

The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines
por: Orellana-Serradell, Octavio, et al.
Publicado: (2019)

Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate
por: CIFUENTES, FEDERICO F., et al.
Publicado: (2015)

The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
por: Orellana-Serradell, Octavio, et al.
Publicado: (2018)

Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer
por: POBLETE, CRISTIAN E., et al.
Publicado: (2014)

Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
por: CASTILLO, VIVIANA, et al.
Publicado: (2014)

SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells
por: OSORIO, LUIS A., et al.
Publicado: (2016)

Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
por: CIFUENTES, FEDERICO F., et al.
Publicado: (2015)

Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer
por: López-Moncada, Fernanda, et al.
Publicado: (2019)

Measurement of labile and protein-bound heme in fixed prostate cancer cells and in cellular fractions
por: Canesin, Giacomo, et al.
Publicado: (2021)

Association among the R.E.N.A.L. nephrometry score and clinical outcomes in patients with small renal masses treated with percutaneous contrast enhanced ultrasound radiofrequency ablation
por: Konstantinidis, Cristian, et al.
Publicado: (2019)

The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer
por: Farfán, Nancy, et al.
Publicado: (2018)

SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells
por: López-Moncada, Fernanda, et al.
Publicado: (2022)

Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC)
por: Arévalo, Jazmine, et al.
Publicado: (2021)

Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
por: LLeonart, Matilde E., et al.
Publicado: (2011)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
por: Axén, Elin, et al.
Publicado: (2021)

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
por: Sequeiros, Tamara, et al.
Publicado: (2016)

Definition of Castrate Resistant Prostate Cancer: New Insights
por: Morote, Juan, et al.
Publicado: (2022)

SNAIL expression correlates with the translocation of syndecan-1 intracellular domain into the nucleus in prostate cancer cell lines
por: Farfán, Nancy, et al.
Publicado: (2020)

Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line
por: Torres, María José, et al.
Publicado: (2021)

Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections
por: Lippolis, Giuseppe, et al.
Publicado: (2013)

Trastornos inmunológicos en lactantes y niños
por: Stiehm, E. Richard, 1933-

Specific Immunotherapy in a Murine Model of Grass Pollen (Phl p5b)-Induced Airway Inflammation
por: Stiehm, Matthias, et al.
Publicado: (2021)

Heme-Derived Metabolic Signals Dictate Immune Responses
por: Canesin, Giacomo, et al.
Publicado: (2020)

HO-1 and Heme: G-Quadruplex Interaction Choreograph DNA Damage Responses and Cancer Growth
por: Canesin, Giacomo, et al.
Publicado: (2021)

Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate‐specific antigen, digital rectal examination and the prostate‐specific antigen density based on digital rectal prostate volume category
por: Morote, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9i1d0sl7afg5e4e2btp8p495l